Citations

Showing 10 of 107969 citations.

Use of Hematopoietic Cell Transplant for Hematologic Cancers by Race, Ethnicity, and Age
Hahn, Theresa , Brazauskas, Ruta , Patel, Jinalben , Saber, Wael , Khera, Nandita , Herr, Megan M. , Ailawadhi, Sikander

Mayo Clinic

JAMA Network Open | September 18, 2024 | Volume: 7 | Issue: 9 | Pages: e2433145

10.1001/jamanetworkopen.2024.33145 | PMID 39292462 Get It

ImportanceUtilization of hematopoietic cell transplantation (HCT) for hematologic cancers previously demonstrated race, ethnicity, and age-based disparities.ObjectiveTo evaluate utilization over time by race, ethnicity, and age to determine if disparities persist in light of recent significant increases in HCT volume.Design, Setting, and ParticipantsThis US population-based retrospective cohort study includes patients who received transplants from January 2009 to December 2018. Data collection and cleaning occurred from February 2019 to November 2021, and data analysis occurred from January 2022 to October 2023. Method 1 restricted the analysis to Surveillance, Epidemiology and End Results (SEER) reporting areas for cases and transplants. Method 2 applied SEER age-, race-, and ethnicity-specific incidence rates to corresponding US census population and included all transplants reported to the Center for International Blood and Marrow Transplant Research. Race and ethnicity groups were hierarchically defined as Hispanic (any race), non-Hispanic White, non-Hispanic Black, and non-Hispanic Other (Asian and American Indian).ExposureReceipt of HCT.Main Outcomes and MeasuresUtilization rate of autologous or allogeneic HCT for patients with hematologic cancers by age, race, and ethnicity.ResultsFrom 2009 to 2018, 136 280 HCTs were analyzed for 6 hematologic cancers comprising 16.7% pediatric/adolescent/young adults (0-39 years), 83.3% adults (40-84 years), 58% male, 10.3% Hispanic, 11.4% non-Hispanic Black, 3.8% non-Hispanic Other, and 74.5% non-Hispanic White patients, with 49 385 allogeneic and 86 895 autologous HCTs performed. HCT utilization increased over time for all disease, age, race, and ethnic groups. From 2017 to 2018, adult (40-84 years) allogeneic transplant utilization for acute myeloid leukemia and myelodysplastic syndrome (MDS) was similar for Hispanic and non-Hispanic White or Other patients but was lower for non-Hispanic Black patients (acute myeloid leukemia: 19% vs 13%; MDS: 9%-10% vs 5%). Similarly, autologous transplant utilization for lymphoma was similar for all race and ethnicity groups; however, autologous transplant for multiple myeloma was highest for non-Hispanic White patients and lower for all other groups (31% vs 26%-27%). In patients aged 0 to 39 years, utilization of allogeneic transplant for acute lymphoblastic leukemia was highest in Hispanic patients, followed by non-Hispanic White, Black, and Other races (acute lymphoblastic leukemia: 19%, 18%, 17%, and 16%, respectively).Conclusions and RelevanceIn this cohort study of autologous and allogeneic transplant utilization for hematologic cancers, disparities persisted for non-Hispanic Black patients. Hispanic, non-Hispanic Other, and younger age groups had increased utilization over time that was on par with non-Hispanic White patients in the most recent cohort.
The Impact of Point-of-Care Ultrasound-Guided Resuscitation on Clinical Outcomes in Patients With Shock: A Systematic Review and Meta-Analysis*
Basmaji, John , Arntfield, Robert , Desai, Karishma , Lau, Vincent , Lewis, Kimberley , Fiorini, Kyle , Slessarev, Marat , Leligdowicz, Aleks, Prager, Ross , Orozco, Nicolás , Meade, Maureen O. , Thabane, Lehana , Guyatt, Gordon, Jones, Philip M. , Thabane, Lehana , Rochwerg, Bram , Honarmand, Kimia , Leligdowicz, Aleksandra , Park, Brian H. , Wong, Michelle Y.S., Ball, Ian Michael , Guyatt, Gordon

Mayo Clinic

Critical Care Medicine | September 18, 2024 | Volume: 52 | Issue: 11 | Pages: 1661-1673

10.1097/ccm.0000000000006399 | PMID 39298556 Get It

OBJECTIVE: To determine the impact of point-of-care ultrasound (POCUS)-guided resuscitation on clinical outcomes in adult patients with shock. DATA SOURCE: We searched MEDLINE, Embase, and unpublished sources from inception to December 2023. STUDY SELECTION: We included randomized controlled trials (RCTs) that examined the use of POCUS to guide resuscitation in patients with shock. DATA EXTRACTION: We collected data regarding study and patient characteristics, POCUS protocol, control group interventions, and outcomes. DATA SYNTHESIS: We identified 18 eligible RCTs. POCUS slightly influences physicians’ plans for IV fluid (IVF) and vasoactive medication prescription (moderate certainty), but results in little to no changes in the administration of IVF (low to high certainty) or inotropes (high certainty). POCUS may result in no change in the number of CT scans performed (low certainty) but probably reduces the number of diagnostic echocardiograms performed (moderate certainty). POCUS-guided resuscitation probably reduces 28-day mortality (relative risk [RR] 0.88; 95% CI, 0.78–0.99), the duration of vasoactive medication (mean difference –0.73 d; 95% CI, –1.16 to –0.30), and the need for renal replacement therapy (RRT) (RR 0.80; 95% CI, 0.63–1.02) (low to moderate certainty evidence), and lactate clearance (high certainty evidence). POCUS-guided resuscitation may results in little to no difference in ICU or hospital admissions, ICU and hospital length of stay, and the need for mechanical ventilation (MV) (low to moderate certainty evidence). There is an uncertain effect on the risk of acute kidney injury and the duration of MV or RRT (very low certainty evidence). CONCLUSIONS: POCUS-guided resuscitation in shock may yield important patient and health system benefits. Due to lack of sufficient evidence, we were unable to explore how the thresholds of operator competency, frequency, and timing of POCUS scans impact patient outcomes.
A population-based survey of Americans with frequent migraine and acute medication use: A plain language summary
Starling, Amaal J. , Cady, Roger , Buse, Dawn C. , Buzby, Meghan, Lenaburg, Kevin

Mayo Clinic

Pain Management | September 18, 2024 | Volume: 14 | Issue: 7 | Pages: 335-345

10.1080/17581869.2024.2392466 | PMID 39292115 Get It

Diversity Scholarships for Plastic Surgery Subinternships: A National Review of US Residency Programs
Rames, Jess D. , Ochoa, Pablo , Bakri, Karim , Rames, Jess, Antezana, Luis A. , Kreutz‐Rodrigues, Lucas , Bakri, Karim

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | September 18, 2024 | Volume: 12 | Issue: 9 | Pages: e6015

10.1097/gox.0000000000006015 | PMID 39296615 Get It

Background: Residency programs have developed monetary initiatives for students underrepresented in medicine (URiM). Our team sought to provide a centralized resource for URiM students seeking plastic surgery subinternships with funded opportunities. Methods: A cross sectional analysis of URiM scholarships offered by US integrated plastic surgery programs (n = 91) between July and September 2023. The study used residency program web domains. Investigators collected information on the monetary value of scholarship, eligibility criteria, and required application documents. Inferential analyses were conducted to investigate whether programs’ geographic region or Doximity ranking played a role in likelihood of scholarship existence. Results: The study found that approximately 52.7% (n = 48) of programs have in place monetary support for underrepresented visiting medical students (eg, stipend or reimbursement). The average monetary support was $1670. A univariate test demonstrated that programs with lower rankings in both reputation and research were less likely to have a scholarship available than higher ranking programs (P = 0.002; P = 0.02, respectively). Programs located in the Midwest regions were 3.5 times more likely to have a diversity scholarship available (P = 0.034). In our multivariate analysis, reputation ranking and geographic region remained significant. A Pearson chi square test showed the greatest proportions of scholarships among geographically similar programs to be in the Midwest (70%), however, not statistically significant. Conclusions: This study provides a centralized resource for URiM students interested in completing away rotations. Further investigation into development of these scholarship opportunities would be of much benefit and could guide other programs in the funding their own diversity scholarships.
Editorial Comment: Fetal Ultrasound, 1.5-T MRI, or 3-T MRI—No Differences in Body Size Parameters at Birth
Watson, Robert E.

Mayo Clinic

American Journal of Roentgenology | September 18, 2024 | Volume: 223 | Issue: 5 | Pages: No page available

10.2214/ajr.24.32037 | PMID 39291950 Get It

VTE Rate in Transgender Surgery: Is it Safe to Continue Estrogen?
Pazelli, Alexandre Meira, Shehab, Abdallah A. , Hussein, Sara , Akpala, Christeebella O. , Bite, Uldis, Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | September 18, 2024 | Volume: 12 | Issue: S8 | Pages: 20-21

10.1097/01.gox.0001063916.79215.96 Get It

Mapping Mandibular Aging in the White Population: AI-Enhanced Shape Analysis of the Lower Facial Third Bony Changes Based on 3D CT Scans of 280 Patients
Hussein, Sara , Rames, Jess D. , Shehab, Abdallah A. , Pazelli, Alexandre Meira, Sears, Victoria A. , Wentworth, Adam, Morris, Jonathan M. , Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | September 18, 2024 | Volume: 12 | Issue: S8 | Pages: 35-36

10.1097/01.gox.0001063996.46231.58 Get It